Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CIGB-814, an altered peptide ligand derived from human heat-shock protein 60, decreases anti-cyclic citrullinated peptides antibodies in patients with rheumatoid arthritis.
Corrales O, Hernández L, Prada D, Gómez J, Reyes Y, López AM, González LJ, Del Carmen Domínguez Horta M. Corrales O, et al. Among authors: prada d. Clin Rheumatol. 2019 Mar;38(3):955-960. doi: 10.1007/s10067-018-4360-3. Epub 2018 Nov 10. Clin Rheumatol. 2019. PMID: 30415439 Clinical Trial.
APL1, an altered peptide ligand derived from human heat-shock protein 60, increases the frequency of Tregs and its suppressive capacity against antigen responding effector CD4 + T cells from rheumatoid arthritis patients.
Barberá A, Lorenzo N, van Kooten P, van Roon J, de Jager W, Prada D, Gómez J, Padrón G, van Eden W, Broere F, Del Carmen Domínguez M. Barberá A, et al. Among authors: prada d. Cell Stress Chaperones. 2016 Jul;21(4):735-44. doi: 10.1007/s12192-016-0698-0. Epub 2016 May 30. Cell Stress Chaperones. 2016. PMID: 27241313 Free PMC article.
A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis.
Rodriguez PC, Torres-Moya R, Reyes G, Molinero C, Prada D, Lopez AM, Hernandez IM, Hernandez MV, Martinez JP, Hernandez X, Casaco A, Ramos M, Avila Y, Barrese Y, Montero E, Hernandez P. Rodriguez PC, et al. Among authors: prada d. Results Immunol. 2012 Nov 21;2:204-11. doi: 10.1016/j.rinim.2012.11.001. eCollection 2012. Results Immunol. 2012. PMID: 24371585 Free PMC article.
Life Cycle Economic and Environmental Assessment for Emerging Heavy-Duty Truck Powertrain Technologies in China: A Comparative Study of Battery Electric, Fuel Cell Electric, and Hydrogen Combustion Engine Trucks.
Xue X, Yan Z, Prada DN, Jia G, Popuri SS, Vijayagopal R, Li Y, Sari RL, Liu C, He X, Amer AA. Xue X, et al. Among authors: prada dn. Environ Sci Technol. 2025 Jan 17. doi: 10.1021/acs.est.4c11737. Online ahead of print. Environ Sci Technol. 2025. PMID: 39823566
Genomic landscape of early-stage prostate adenocarcinoma in Mexican patients: an exploratory study.
Cerrato-Izaguirre D, González-Ruíz J, Diaz-Chavez J, Ramírez A, Scavuzzo A, Jimenez MA, Cortés-González C, Rubio JA, Pérez-Montiel MD, García-Cuellar CM, Herrera LA, Sánchez-Pérez Y, Vaca-Paniagua F, Barquet-Muñoz S, Cantu-de-Leon D, Bose P, Prada D. Cerrato-Izaguirre D, et al. Among authors: prada d. Discov Oncol. 2024 Aug 28;15(1):378. doi: 10.1007/s12672-024-01199-3. Discov Oncol. 2024. PMID: 39196408 Free PMC article.
Predictors of Endocrine Resistance in a Cohort of Mexican Breast Cancer Patients.
González-Ruíz J, Terry MB, Cabrera-Galeana P, Monroy-Chargoy A, Horowitz C, Bickel N, García-Cuellar C, Ramírez A, Bargalló E, Diaz-Chavez J, Barquet-Muñoz S, Cantú-de-León D, Prada D. González-Ruíz J, et al. Among authors: prada d. Res Sq [Preprint]. 2024 May 30:rs.3.rs-4414887. doi: 10.21203/rs.3.rs-4414887/v1. Res Sq. 2024. PMID: 38853915 Free PMC article. Preprint.
126 results